首页> 外文期刊>Oncology letters >miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2
【24h】

miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2

机译:miR-154通过靶向ZEB2抑制人非小细胞肺癌的迁移和侵袭

获取原文
获取原文并翻译 | 示例
           

摘要

Emerging evidence suggests that microRNAs (miRs) play critical roles in the development and progression of non-small cell lung cancer (NSCLC). In a previous study, the present authors demonstrated that miR-154 acts as a tumor suppressor in NSCLC; however, its underlying molecular mechanism and target in NSCLC remain poorly understood. In the present study, ectopic expression of miR-154 remarkably suppressed cell migration and invasion in NSCLC cells. Zinc finger E-box binding homeobox 2 (ZEB2) was identified as a direct target of miR-154 in NSCLC cells. Furthermore, overexpression of miR-154 could decrease the expression of ZEB2 at the messenger RNA and protein levels. Ectopic expression of miR-154 also increased the levels of E-cadherin, an epithelial marker, and decreased the levels of vimentin, a mesenchymal marker, which contributed to suppress epithelial-mesenchymal transition (EMT) and to inhibit cell migration and invasion. In addition, downregulation of ZEB2 exerted similar effects to those caused by miR-154 overexpression on NSCLC cell migration and invasion, while upregulation of ZEB2 could significantly reverse the inhibitory effects on migration and invasion caused by miR-154 on NSCLC cells. These findings demonstrated that miR-154 inhibited migration and invasion of NSCLC cells by regulating EMT through targeting ZEB2, suggesting that miR-154 may be a potential anticancer therapeutic target for NSCLC.
机译:新兴证据表明,microRNA(miR)在非小细胞肺癌(NSCLC)的发生和发展中起着至关重要的作用。在先前的研究中,作者证明了miR-154在NSCLC中起着抑癌作用。然而,其在NSCLC中的潜在分子机制和靶标仍然知之甚少。在本研究中,miR-154的异位表达显着抑制了NSCLC细胞中的细胞迁移和侵袭。锌指E-box结合同源盒2(ZEB2)被确定为NSCLC细胞中miR-154的直接靶标。此外,miR-154的过表达可能在信使RNA和蛋白质水平上降低ZEB2的表达。 miR-154的异位表达还增加了上皮标记物E-cadherin的水平,并降低了间质标记物波形蛋白的水平,这有助于抑制上皮-间质转化(EMT)并抑制细胞迁移和侵袭。此外,ZEB2的下调与miR-154过表达对NSCLC细胞迁移和侵袭产生的作用相似,而ZEB2的上调则可以显着逆转miR-154对NSCLC细胞的侵袭和侵袭的抑制作用。这些发现表明,miR-154通过靶向ZEB2调节EMT抑制了NSCLC细胞的迁移和侵袭,表明miR-154可能是NSCLC的潜在抗癌治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号